Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eliza Hawkes

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Clinical Colorectal Cancer|January 7, 2011
Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancerUzma Asghar, Eliza Hawkes, David Cunningham
Hematological Oncology|July 12, 2023
Diffuse large B-cell lymphomaAllison Barraclough, Eliza Hawkes, Laurie H Sehn, et al.
Oncology|July 3, 2019
Effect of Reasons for Screen Failure on Subsequent Treatment Outcomes in Cancer Patients Assessed for Clinical TrialsCrescens Tiu, Zoe Loh, Chun Loo Gan, et al.
Pathology|May 11, 2023
Increased STAT expression in Reed-Sternberg cells as a potential positive prognostication biomarker in Hodgkin lymphomaAhmad Zargari, Katherine D Cummins, Patrick Hosking, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 6, 2022
The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic reviewZahra Kiamanesh, Narjess Ayati, Ramin Sadeghi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2021
Exploration of motivation to participate in a study of cancer-related cognitive impairment among patients with newly diagnosed aggressive lymphoma: a qualitative sub-studyPriscilla Gates, Haryana Dhillon, Karla Gough, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2011
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancerEliza Hawkes, Alicia F C Okines, Demetris Papamichael, et al.
European Journal of Haematology|July 9, 2021
Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphomaJoel Wight, Shin Hnin Wai, Edward Shen, et al.
BMJ Open|September 30, 2020
Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility studyPriscilla Gates, Karla Gough, Haryana Dhillon, et al.
Internal Medicine Journal|August 5, 2024
Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceJoshua W D Tobin, Greg Hapgood, Anna Johnston, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Clinical Colorectal Cancer|January 7, 2011
Predictive and prognostic biomarkers for targeted therapy in metastatic colorectal cancerUzma Asghar, Eliza Hawkes, David Cunningham
Hematological Oncology|July 12, 2023
Diffuse large B-cell lymphomaAllison Barraclough, Eliza Hawkes, Laurie H Sehn, et al.
Oncology|July 3, 2019
Effect of Reasons for Screen Failure on Subsequent Treatment Outcomes in Cancer Patients Assessed for Clinical TrialsCrescens Tiu, Zoe Loh, Chun Loo Gan, et al.
Pathology|May 11, 2023
Increased STAT expression in Reed-Sternberg cells as a potential positive prognostication biomarker in Hodgkin lymphomaAhmad Zargari, Katherine D Cummins, Patrick Hosking, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 6, 2022
The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic reviewZahra Kiamanesh, Narjess Ayati, Ramin Sadeghi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 8, 2021
Exploration of motivation to participate in a study of cancer-related cognitive impairment among patients with newly diagnosed aggressive lymphoma: a qualitative sub-studyPriscilla Gates, Haryana Dhillon, Karla Gough, et al.
European Journal of Cancer (Oxford, England : 1990)|January 29, 2011
Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancerEliza Hawkes, Alicia F C Okines, Demetris Papamichael, et al.
European Journal of Haematology|July 9, 2021
Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphomaJoel Wight, Shin Hnin Wai, Edward Shen, et al.
BMJ Open|September 30, 2020
Longitudinal exploration of cancer-related cognitive impairment in patients with newly diagnosed aggressive lymphoma: protocol for a feasibility studyPriscilla Gates, Karla Gough, Haryana Dhillon, et al.
Internal Medicine Journal|August 5, 2024
Diagnosis, management and follow-up of follicular lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceJoshua W D Tobin, Greg Hapgood, Anna Johnston, et al.
Pageof 3